立即与逐步降低香烟尼古丁含量对烟雾暴露生物标志物的影响:一项随机临床试验
该双盲随机对照试验在美国10个中心纳入1250名无近期戒烟意愿的每日吸烟者,比较立即降至0.4 mg尼古丁/克烟草、逐步从15.5 mg降至0.4 mg(每月5次剂量调整)及维持15.5 mg对20周干预期间烟雾毒性暴露生物标志物的影响。结果显示立即降低组CO、3-HPMA和PheT均显著低于逐步降低组和对照组,而逐步降低组与对照组无显著差异。
要点
- 立即降低香烟尼古丁含量可显著降低烟雾毒性暴露生物标志物。
- 逐步降低尼古丁含量对烟雾暴露生物标志物无显著改善。
- 研究纳入无30天内戒烟意愿的每日吸烟者,结果需结合人群特征解读。
核心结论
- 立即降低香烟尼古丁含量至0.4 mg/克烟草较逐步降低或维持常规水平显著降低烟雾暴露生物标志物。
- 逐步降低尼古丁含量与维持常规水平相比,烟雾暴露生物标志物无显著差异。
研究设计与样本
- 双盲、随机、平行设计研究,包含2周基线吸烟期和20周干预期。
- 在美国10个中心开展,2014年7月至2016年9月招募每日吸烟者,末次随访于2017年3月完成。
- 共随机1250名参与者,平均年龄45岁,女性549名(44%),958名(77%)完成试验。
主要发现
- 立即降低组 vs 逐步降低组:CO平均差异-4.06 ppm(95%CI -4.89至-3.23;P<.0055),3-HPMA几何均值比0.83(95%CI 0.77至0.88;P<.0055),PheT几何均值比0.88(95%CI 0.83至0.93;P<.0055)。
- 立即降低组 vs 对照组:CO平均差异-3.38(95%CI -4.40至-2.36;P<.0055),3-HPMA几何均值比0.81(95%CI 0.75至0.88;P<.0055),PheT几何均值比0.86(95%CI 0.81至0.92;P<.0055)。
- 逐步降低组 vs 对照组:CO平均差异0.68(95%CI -0.31至1.67;P=.18),3-HPMA几何均值比0.98(95%CI 0.91至1.06;P=.64),PheT几何均值比0.98(95%CI 0.92至1.04;P=.52),均无显著差异。
关键数值与推荐
- 干预措施:立即降至0.4 mg尼古丁/克烟草;逐步从15.5 mg降至0.4 mg(5次每月剂量调整);或维持15.5 mg尼古丁/克烟草。
- 主要结局为20周干预期间CO、3-HPMA和PheT的浓度-时间曲线下面积组间差异。
临床怎么用
- 对于无近期戒烟意愿的每日吸烟者,立即降低香烟尼古丁含量至0.4 mg/克烟草可能比逐步降低更有效减少烟雾毒性暴露。
- 逐步降低尼古丁含量策略在本研究中未显示显著降低烟雾暴露生物标志物的效果。
局限性
- 研究纳入无30天内戒烟意愿的志愿者,结果外推至其他吸烟人群需谨慎。
- 仅23%的随机参与者未完成试验,可能存在失访偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The optimal temporal approach for reducing nicotine to minimally or nonaddictive levels in all cigarettes sold in the United States has not been determined. OBJECTIVES: To determine the effects of immediate vs gradual reduction in nicotine content to very low levels and as compared with usual nicotine level cigarettes on biomarkers of toxicant exposure. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, parallel-design study with 2 weeks of baseline smoking and 20 weeks of intervention was conducted at 10 US sites. A volunteer sample of daily smokers with no intention to quit within 30 days was recruited between July 2014 and September 2016, with the last follow-up completed in March 2017. INTERVENTIONS: (1) Immediate reduction to 0.4 mg of nicotine per gram of tobacco cigarettes; (2) gradual reduction from 15.5 mg to 0.4 mg of nicotine per gram of tobacco cigarettes with 5 monthly dose changes; or (3) maintenance on 15.5 mg of nicotine per gram of tobacco cigarettes. MAIN OUTCOMES AND MEASURES: Between-group differences in 3 co-primary biomarkers of smoke toxicant exposure: breath carbon monoxide (CO), urine 3-hydroxypropylmercapturic acid (3-HPMA, metabolite of acrolein), and urine phenanthrene tetraol (PheT, indicator of polycyclic aromatic hydrocarbons) calculated as area under the concentration-time curve over the 20 weeks of intervention. RESULTS: Among 1250 randomized participants (mean age, 45 years; 549 women [44%]; 958 [77%] completed the trial), significantly lower levels of exposure were observed in the immediate vs gradual reduction group for CO (mean difference, -4.06 parts per million [ppm] [95% CI, -4.89 to -3.23]; P < .0055), 3-HPMA (ratio of geometric means, 0.83 [95% CI, 0.77 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.88 [95% CI, 0.83 to 0.93]; P < .0055). Significantly lower levels of exposure were observed in the immediate reduction vs control group for CO (mean difference, -3.38 [95% CI, -4.40 to -2.36]; P < .0055), 3-HPMA (ratio of geometric means, 0.81 [95% CI, 0.75 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.86 [95% CI, 0.81 to 0.92]; P < .0055). No significant differences were observed between the gradual reduction vs control groups for CO (mean difference, 0.68 [95% CI, -0.31 to 1.67]; P = .18), 3-HPMA (ratio of geometric means, 0.98 [95% CI, 0.91 to 1.06]; P = .64), and PheT (ratio of geometric means, 0.98 [95% CI, 0.92 to 1.04]; P = .52). CONCLUSIONS AND RELEVANCE: Among smokers, immediate reduction of nicotine in cigarettes led to significantly greater decreases in biomarkers of smoke exposure across time compared with gradual reduction or a control group, with no significant differences between gradual reduction and control. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02139930.
引用
- Hatsukami DK, Luo X, Jensen JA, et al. Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA. 2018. PMID: 30193275. doi:10.1001/jama.2018.11473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。